Post by ten23 health

🌟We are proud to share that Lea Sorret from ten23 health, will speak at the 2026 Colorado Protein Stability Conference, taking place August 3–6 in Breckenridge, #Colorado. On August 6, as part of the dedicated ADCs and Excipients session, Lea will present "Integrated Drug Product Development and Clinical Administration Strategies of Antibody-Drug Conjugates." Antibody-drug conjugates carry a cytotoxic payload on an antibody backbone, which means stability, clinical administration risk cannot be solved in isolation — they have to be designed for together, from early formulation development through to the clinic. This is where ten23 health operates. Our integrated development pathway connects formulation and process development with clinical in-use simulation, addressing the containment, particle characterization, and drug-device considerations that high-potency biologics like ADCs demand — so that safe, scalable administration is designed in from day one, not solved for later. Congratulations to Lea on this invitation, and thank you to the University of Colorado Anschutz / School of Pharmacy for convening this community of scientists working on the hardest problems in protein stability. Here's more info on the program: https://ow.ly/JCvu50ZmNIL #AntibodyDrugConjugates #ProteinStability #DrugProductDevelopment #Biopharmaceuticals #CDMO #PharmaceuticalScience #ten23health

Video Content